Minimally Invasive Protocols for the Treatment and Control of Caries Lesions in Children and Adolescents
NCT ID: NCT06999005
Last Updated: 2026-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
2500 participants
INTERVENTIONAL
2026-02-28
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Progression of Active Microcavitated Carious Lesions on Primary Molar Occlusal Surfaces
NCT04127357
Management of Occlusal Caries Using Silver Modified Atraumatic Restorative Treatment Versus Atraumatic Restorative Treatment
NCT04354636
Cost-efficacy of Sealing Moderate Caries Lesions in Occlusal Surfaces of Primary Molars
NCT03005405
Effectiveness of Silver Diamine Fluoride in Arresting Dental Caries
NCT03063307
Comparing Minimally Invasive Techniques Used in Treatment of Carious Primary Molars in Children
NCT06592885
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the first phase, approximately 50,000 children aged 6-12 years will undergo dental screening using the International Caries Detection and Assessment System (ICDAS). All children will receive health literacy activities, oral hygiene instructions, toothbrushes, fluoride toothpaste (1,100 ppm), and a single application of fluoride varnish (Duraphat®) to permanent molars and incisors.
Children identified with active caries lesions (ICDAS 1-6) will be considered for the second phase. A total of 2,500 participants will be selected and allocated to one of the following four intervention protocols based on clinical diagnosis:
Protocol 1: Single application of fluoride varnish for prevention. Protocol 2: Four weekly applications of fluoride varnish for active white spot lesions, followed by quarterly applications.
Protocol 3: High-viscosity glass ionomer ART sealants (for ICDAS 3), with quarterly fluoride varnish.
Protocol 4: Conventional atraumatic restorative treatment (ART) with glass ionomer (for ICDAS 4-6), plus quarterly fluoride varnish.
Participants will be followed up every three months over a 24-month period.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Preventive Varnish Application (Protocol 1)
Children with no visible carious lesions or early non-cavitated enamel lesions (ICDAS 0 to 2) will receive a single application of Duraphat® fluoride varnish (Colgate®) on first permanent molars and permanent incisors. The varnish will be applied using cotton swabs, following drying of the surfaces. This protocol aims to provide preventive sealing and will be reapplied every three months.
Fluoride Varnish Application (Preventive Protocol)
Single application of Duraphat® fluoride varnish on permanent molars and incisors, repeated every 3 months.
Active White Spot Lesion Treatment (Protocol 2)
Children diagnosed with active enamel caries lesions (ICDAS 1 to 3) will receive Duraphat® fluoride varnish (Colgate®) in four weekly sessions to promote lesion arrest and remineralization. After lesion inactivation, quarterly reapplications will be performed. For first molars and incisors without lesions but still erupting (with gingival operculum), quarterly varnish applications will also be provided.
Fluoride Varnish for Active Enamel Lesions
Weekly fluoride varnish applications for 4 weeks, followed by quarterly maintenance applications.
ART Sealant Application (Protocol 3)
Children with occlusal lesions classified as ICDAS 3 or at high risk of caries will receive ART sealants (Atraumatic Restorative Treatment) using high-viscosity glass ionomer cement. The protocol includes professional cleaning, relative isolation, placement of the material, finger pressure sealing, and final fluoride varnish application. Quarterly evaluations and varnish reapplications will be conducted.
Atraumatic Restorative Treatment (ART) Sealant
Sealant placement with high-viscosity glass ionomer using the ART technique, with quarterly fluoride varnish.
Atraumatic Restorative Treatment (Protocol 4)
Children with dentin-level carious lesions (ICDAS 4 to 6) and pulpal vitality will receive cavity cleaning with cotton pellets and caries removal using manual excavators and PapacarieDUO® gel. The cavity will be restored with high-viscosity glass ionomer cement using finger pressure technique. Fluoride varnish will be applied afterward. Quarterly follow-ups will include clinical evaluation and retreatment if necessary.
Atraumatic Restorative Treatment (ART)
Manual caries removal and cavity restoration with glass ionomer cement, followed by fluoride varnish every 3 months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fluoride Varnish Application (Preventive Protocol)
Single application of Duraphat® fluoride varnish on permanent molars and incisors, repeated every 3 months.
Fluoride Varnish for Active Enamel Lesions
Weekly fluoride varnish applications for 4 weeks, followed by quarterly maintenance applications.
Atraumatic Restorative Treatment (ART) Sealant
Sealant placement with high-viscosity glass ionomer using the ART technique, with quarterly fluoride varnish.
Atraumatic Restorative Treatment (ART)
Manual caries removal and cavity restoration with glass ionomer cement, followed by fluoride varnish every 3 months.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presence of at least one erupted permanent first molar
* Diagnosis of active caries lesions classified according to ICDAS (scores 1 to 6)
* Written informed consent signed by a legal guardian and assent signed by the child
* Ability to attend quarterly follow-up visits over a 24-month period
Exclusion Criteria
* Presence of systemic diseases or medical conditions that contraindicate dental care
* Known allergy to any material used in the study (fluoride varnish, high-viscosity glass ionomer cement)
* Participation in other clinical dental studies that could interfere with the outcomes
6 Years
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Nove de Julho
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sandra Kalil Bussadori
Principal Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
100YEARMOLAR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.